Iron
- Generic Name
- Iron
- Brand Names
- Citranatal B-calm Kit, Citranatal Harmony, Concept Ob, Ferralet 90, Natafort, Vitafol-one
- Drug Type
- Small Molecule
- Chemical Formula
- Fe
- CAS Number
- 7439-89-6
- Unique Ingredient Identifier
- E1UOL152H7
- Background
A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-defi...
- Indication
Used in preventing and treating iron-deficiency anemia.
- Associated Conditions
- Anemia, Iron Deficiency (ID), Iron Deficiency Anemia (IDA), Restless Legs Syndrome (RLS), Concomitant myelosuppressive chemotherapy
- Associated Therapies
- Nutritional supplementation, Dietary supplementation
Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)
- Conditions
- Interventions
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2020-10-06
- Lead Sponsor
- Pharmacosmos A/S
- Target Recruit Count
- 1512
- Registration Number
- NCT02940886
- Locations
- 🇺🇸
Pharmacosmos Investigational Site, Tacoma, Washington, United States
🇺🇸Pharmacosmos Investigational Site 1, East Setauket, New York, United States
🇺🇸Pharmacosmos Investigational Site 2, East Setauket, New York, United States
Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents
- First Posted Date
- 2016-07-12
- Last Posted Date
- 2019-12-03
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 28
- Registration Number
- NCT02829320
- Locations
- 🇯🇵
GSK Investigational Site, Yamagata, Japan
Treatment Response in Dialysis Anaemia
- Conditions
- Interventions
- First Posted Date
- 2016-03-14
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- Imperial College Healthcare NHS Trust
- Target Recruit Count
- 197
- Registration Number
- NCT02707757
- Locations
- 🇬🇧
Imperial Renal and Transplant Centre, London, United Kingdom
🇬🇧Imperial NHS Healthcare Trust, London, United Kingdom
Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial
- Conditions
- Interventions
- First Posted Date
- 2015-10-01
- Last Posted Date
- 2021-12-02
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 4
- Registration Number
- NCT02564796
- Locations
- 🇺🇸
Rady Children's Hospital, San Diego, California, United States
Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.
- Conditions
- Interventions
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2015-03-19
- Lead Sponsor
- Hospital Aleman
- Target Recruit Count
- 40
- Registration Number
- NCT02392910
- Locations
- 🇦🇷
Hospital Aleman, Buenos Aires, Caba, Argentina
Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis
- Conditions
- Interventions
- First Posted Date
- 2014-10-30
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Astellas Pharma Europe B.V.
- Target Recruit Count
- 838
- Registration Number
- NCT02278341
- Locations
- 🇵🇱
Site PL48002, Katowice, Poland
🇭🇷Site HR38509, Zagreb, Grad Zagreb, Croatia
🇭🇷Site HR38505, Karlovac, Croatia
Supplementing Iron and Development in Breastfed Infants (SIDBI Study)
- First Posted Date
- 2014-09-16
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Medical University of Warsaw
- Target Recruit Count
- 220
- Registration Number
- NCT02242188
- Locations
- 🇵🇱
Department of Pediatrics, The Medical University of Warsaw, Warsaw, Poland
RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone
- Conditions
- Interventions
- First Posted Date
- 2014-01-28
- Last Posted Date
- 2019-04-03
- Lead Sponsor
- Denver Health and Hospital Authority
- Registration Number
- NCT02047552
- Locations
- 🇺🇸
Denver Health Medical Center, Denver, Colorado, United States
Randomized Study Comparing Ferric Carboxymaltose to Iron Sucrose to Treat Fe Deficiency in the Surgically Critically Ill
- Conditions
- Interventions
- First Posted Date
- 2013-12-12
- Last Posted Date
- 2018-01-12
- Lead Sponsor
- Denver Health and Hospital Authority
- Registration Number
- NCT02009943
- Locations
- 🇺🇸
Denver Health Medical Center, Denver, Colorado, United States
The Benefits of a Preoperative Anemia Management Program
- Conditions
- Interventions
- First Posted Date
- 2013-06-27
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 51
- Registration Number
- NCT01888003
- Locations
- 🇺🇸
UAB Highlands Hospital, Birmingham, Alabama, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.